Human DR3/TNFRSF25 Antibody, R&D Systems™

DR3/TNFRSF25

Polyclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

Apo-3, APO3, Apoptosis-inducing receptor AIR, Apoptosis-mediating receptor DR3, Apoptosis-mediating receptor TRAMP, Death receptor 3, DR3member 12 (translocatingchain-association membrane protein), LARD, Lymphocyte-associated receptor of death, Protein WSL, Protein WSL-1, TNFRSF25, TRAMP, tumor necrosis factor receptor superfamily, member 25, WSL, WSL1, WSL-1

Goat

Affinity Purified

RUO

8718

Reconstitute at 0.2 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Western Blot

LYOPH

Western Blot 0.1 ug/mL

Q93038

TNFRSF25

Mouse myeloma cell line NS0-derived recombinant human DR3/TNFRSF25 Gln25-Phe201 Accession # Q93038

25 μg

Primary

Detects human DR3/TNFRSF25 in direct ELISAs and Western blots. In direct ELISAs, approximately 5% cross-reactivity with recombinant mouse DR3 is observed, and less than 1% cross-reactivity with recombinant human (rh) Fas, rhTNF RI, rhDR6, rh4-1BB, rhCD27, rhCD30, rhCD40, rhGITR, rhHVEM, rhTNF RII and rhOPG is observed.

Human

IgG